Igyxos’ IGX12 brings a fresh approach to infertility treatment, aiming to improve outcomes for both men and women.

Delve into Vandria's technology and its Alzheimer's candidate, VNA-318, the first mitophagy-based candidate in Alzheimer's in ...

A new wave of metabolic disease drugs beyond GLP-1 agonists is emerging to address the unmet needs of patients.

Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma companies.

Discover the emergence of dual-payload ADCs and PDCs, which could mark a significant evolution in targeted therapeutics.

For over a hundred years, psychiatry has existed at the intersection of science and art. Unlike other fields of medicine, which rely on blood tests, cultures, imaging, or tissue samples for diagnosis, ...

Prader-Willi syndrome is a rare genetic condition that leads to physical and behavioral problems. A common feature of the condition is feeling hungry all the time, and people with Prader-Willi have an ...

Once a booming field, bustling with innovation and money driving that innovation, the cell and gene therapy sector is now struggling to fuel therapeutic growth to bring medicines to patients. It doesn ...

Genetically modified crops, or genetically engineered crops, are essentially plants that have had their DNA altered through the process of genetic engineering. By editing, removing, or inserting ...

Genome Valley, the 2,000-acre life sciences cluster just outside Hyderabad, is at the heart of Telangana’s claim to being the “vaccine capital of the world.” Data show the region produces around ...

California-based Cargo Therapeutics has had a rough year with its CAR-T cell therapy firicabtagene autoleucel being discontinued after patients experienced toxic side effects in the clinic. The ...